ENTYVIO® Vedolizumab 300 mg Injection

Name: Integrin Receptor Antagonist
Brand: ENTYVIO®

ENTYVIO VEDOLIZUMAB, SDV 300MG

McKesson #

1217082

Manufacturer #

64764030020

Brand

ENTYVIO®

Manufacturer

Takeda Pharmaceuticals America Inc

Country of Origin

Unknown

Application

Integrin Receptor Antagonist

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Name

Vedolizumab

NDC Number

64764030020

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

300 mg

Type

Intravenous

UNSPSC Code

51201572

ENTYVIO is indicated in adults for the treatment of: moderately to severely active ulcerative colitis; moderately to severely active Crohn's disease
Refrigerate unopened vials at 2ºC to 8ºC (36ºF to 46ºF)
Retain in original package to protect from light
Must be reconstituted and diluted prior to use